The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Wall Street set for weak open on hedge fund-retail battle

Fri, 29th Jan 2021 12:22

* U.S. futures, European stocks drop 0.5-0.8%

* Dollar index eyes weekly gain

* GameStop price nearly doubles in U.S. pre-market

* Bitcoin jumps 14% after Elon Musk mention

By Carolyn Cohn

LONDON, Jan 29 (Reuters) - U.S. stock futures and European
stocks fell on Friday while the safe-haven dollar held its
ground as a Wall Street battle between hedge funds and retail
investors and a row in Europe over COVID-19 vaccine supply
cooled risk appetite.

Wall Street has been gripped by an assault by small traders
organising over online forums, such as Reddit, to force hedge
funds to reverse short positions - or bets that stocks would
fall - on companies such as GameStop and AMC
Entertainment.

The stand-off comes after central bank and government
stimulus have propelled stock markets to record highs in recent
weeks, encouraging involvement by retail investors.

"There's fear in terms of the volatility," said Derek
Halpenny, head of research for global markets at MUFG. "Specific
trades in pockets of the market can spread into the broader
market."

Shares in GameStop, AMC Entertainment and
BlackBerry plunged more than 40% on Thursday after
several online platforms imposed buying halts, but rebounded as
Robinhood and Interactive Brokers eased the restrictions on
Friday.

GameStop shares nearly doubled and AMC Entertainment was up
55% in U.S. pre-market trade.

"Any hedge fund will be carefully looking at all their
shorts after this week and regulators will look very carefully
at collective retail trading," Deutsche Bank analysts said.

S&P 500 futures recouped some ground in European
trade but were down 0.5% by 1138 GMT. Nasdaq 100 futures
fell 0.7% .

Britain's FTSE 100 index fell 0.8% and European
stocks dropped 0.7%.

VACCINE ROW

Delays in COVID-19 vaccine production have snowballed into a
spat between Britain, the European Union and drugmakers over how
best to direct limited supplies.

AstraZeneca offered eight million more doses of its
COVID-19 vaccine to the European Union, after it unexpectedly
announced cuts in supplies last week. But the bloc said that was
far short of what was originally promised, an EU official told
Reuters on Friday.

New variants of the novel coronavirus have also prolonged
lockdowns and delayed expectations of an economic rebound.

Barclays analysts, however, said that "institutional
positioning is not aggressive overall, and as long as vaccines
work and central banks stay put, buy-the-dip mentality should
continue".

Click here http://tmsnrt.rs/2EmTD6j for an interactive chart
on the vaccine race

The U.S. dollar rose to its highest since mid-November
against the yen, and was steady against an index of
currencies, bringing its weekly rise to 0.4%. The euro
edged up 0.1% and the pound was steady.

Bitcoin jumped as much as 14% to a two-week high
after Tesla Inc TSLA.O chief Elon Musk tagged the cryptocurrency
in his Twitter biography.

French 10-year government bond yields, which
move inversely to price, rose four basis points after France's
gross domestic product contracted less than expected in the
fourth quarter of 2020.

World stocks fell 0.4% towards three-week
lows set in the previous session, and were heading for a weekly
fall of more than 2%.

MSCI's broadest index of Asia-Pacific shares outside Japan
fell 1%, on course for a weekly loss of 4.4%.
Japan's Nikkei fell 1.9%, recording its first weekly
loss of the year.

The People's Bank of China (PBOC) injected 100 billion yuan
into the financial system on Friday, following a week of
reducing liquidity, which had sparked concerns the central bank
was in fact tightening monetary policy.

The extra money did little to loosen short-term money
markets, where rates rose for a fifth straight day and benchmark
overnight repo rates surged to their highest in
nearly six years.

Oil prices rose within recent ranges, with concerns caused
by the new coronavirus variants and slow vaccine rollouts
offsetting a cut in Saudi Arabian oil supply and falling U.S.
oil inventories.

Brent crude futures were up 0.88% at $56.02 a barrel
and U.S. crude futures rose 0.5% to $52.60 a barrel.

Gold benefited from demand for safer assets, rising
1.1%.

(Additional reporting by Tom Westbrook in Singapore and Alwyn
Scott in New York; Editing by Richard Pullin, Ana Nicolaci da
Costa, William Maclean, Larry King)

More News
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.